glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial
Here we show that deletion of a single gene, gliT , in the gliotoxin biosynthetic cluster of two A
For each medication cohort, the use of other drugs of interest (i.e., SGLT2i, ACEi/ARB, GLP-1 RA, steroidal MRA [sMRA]) relative to the index medication was classified into three distinct time periods relative to the index date: within 90 days before, on, and within 90 days after, respectively
The mechanistic contrast matters clinically: a satiety-hormone agonist and a central stimulant produce different side-effect profiles, different cardiovascular considerations, and different rules about how long a patient can stay on the drug
How to Keep Your GLP-1 Cold on the Road Keeping your medication cold is key when traveling with a GLP-1 injection
Consult your physician about the WBCIL liposomal glutathione advantage now.